Antengene, Hansoh Pharma partner to commercialise Xpovio in Mainland China
Under the agreement, Antengene will retain its responsibilities for R&D, regulatory approvals and affairs, product supply, and distribution…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
11 Aug 23
Under the agreement, Antengene will retain its responsibilities for R&D, regulatory approvals and affairs, product supply, and distribution…
11 Aug 23
Under the collaboration, Boostimmune will have access to WuXi Biologics' integrated discovery services and extensive expertise in antibody…
11 Aug 23
World's largest franchise operator will lead efforts to hyperscale Wendy's® and grow the brand across the country
11 Aug 23
Preclinical research published in Nature Communications details safety and effectiveness of the investigational therapy now in a Phase…
11 Aug 23
Make ahead and on-the-go options for busy mornings
11 Aug 23
Healthrageous, a leading innovator in the Food-Is-Medicine movement, is transforming Medicare Advantage plans by integrating meals as a…
11 Aug 23
Brand Builds on Its Decades Long Partnership with the NFL to Give Away the First-Ever No. 0 Jerseys…
10 Aug 23
Informally referred to as Eris, the new strain descends from the lineage of XBB.1.9.2, and would pose relatively…
10 Aug 23
As part of the expansion of the Milan site, AGC Biologics has added five suspension single-use bioreactors, including…
10 Aug 23
Under the agreement, T-MAXIMUM Biotech will get several CRISPR reagents from GenScript to aid in the development of…